Functional expression of human DNA topoisomerase I and its subcellular localization in HeLa cells

被引:34
作者
Mo, YY
Wang, PC
Beck, WT [1 ]
机构
[1] Univ Illinois, Dept Mol Genet, Div Mol Pharmacol, Chicago, IL 60607 USA
[2] Univ Illinois, Dept Pharmaceut & Phamacodynam, Chicago, IL 60607 USA
关键词
topoisomerase I; EGFP fusion; expression; subcellular localization;
D O I
10.1006/excr.2000.4864
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA topoisomerase (topo) I plays an important role in DNA metabolism by relieving the torsional restraints of DNA topology through ATP-independent single-strand DNA breakage. In the present study, we expressed human topo I in HeLa cells by fusing it to enhanced green fluorescent protein (EGFP), The EGFP-topo I fusion protein is functionally active in that it relaxes supercoiled plasmid DNA; forms complexes with DNA, as revealed by band depletion assays; and increases the sensitivity of cells to topo I inhibitors such as topotecan, as determined by growth inhibition assays, In contrast, a mutant form of the EGFP-topo I fusion protein, in which the active Tyr has been replaced by Phe (Y723F), has no such activities. Furthermore, the fusion protein localizes to the nucleus at interphase and completely associates with chromatids at every stage of mitosis, Of importance, the mutant fusion protein (Y723F) displays a pattern of subcellular localization identical to that of the wildtype fusion protein, although the mutant fusion protein is catalytically inactive, These results suggest that in addition to its role in DNA metabolism, topo I might also play a structural role in chromosomal organization; moreover, the association of topo I with chromosomal DNA is independent of its catalytic activity. Finally, the fusion constructs may provide a useful tool to study drug action in tumor cells, as demonstrated by nucleolar delocalization of the fusion proteins in response to treatment with the topo I inhibitor topotecan, (C) 2000 Academic Press.
引用
收藏
页码:480 / 490
页数:11
相关论文
共 40 条
[1]  
ALSNER J, 1992, J BIOL CHEM, V267, P12408
[2]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[3]   CELL-CYCLE ANALYSIS OF AMOUNT AND DISTRIBUTION OF NUCLEAR-DNA TOPOISOMERASE-I AS DETERMINED BY FLUORESCENCE DIGITAL IMAGING MICROSCOPY [J].
BAKER, SD ;
WADKINS, RM ;
STEWART, CF ;
BECK, WT ;
DANKS, MK .
CYTOMETRY, 1995, 19 (02) :134-145
[4]   Identification of a nucleolin binding site in human topoisomerase I [J].
Bharti, AK ;
Olson, MOJ ;
Kufe, DW ;
Rubin, EH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :1993-1997
[5]  
Buckwalter CA, 1996, CANCER RES, V56, P1674
[6]   Mitotic chromosome condensation in the rDNA requires TRF4 and DNA topoisomerase I in Saccharomyces cerevisiae [J].
Castano, IB ;
Brzoska, PM ;
Sadoff, BU ;
Chen, HY ;
Christman, MF .
GENES & DEVELOPMENT, 1996, 10 (20) :2564-2576
[7]   DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS [J].
CHEN, AY ;
LIU, LF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :191-218
[8]  
Danks MK, 1996, CANCER RES, V56, P1664
[9]  
DARPA P, 1990, CANCER RES, V50, P6919
[10]   CDNA CLONING OF HUMAN DNA TOPOISOMERASE-I - CATALYTIC ACTIVITY OF A 67.7-KDA CARBOXYL-TERMINAL FRAGMENT [J].
DARPA, P ;
MACHLIN, PS ;
RATRIE, H ;
ROTHFIELD, NF ;
CLEVELAND, DW ;
EARNSHAW, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2543-2547